Endocyte, Inc. (ECYT) Tops Q4 Loss Views by 4c

Endocyte, Inc. (NASDAQ: ECYT) reported Q4 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Tenon Medical (TNON) Misses Q2 EPS by 395c
• Braze Inc (BRZE) PT Raised to $35 at BTIG